Altimmune, Inc. Business Finance Contracts & Agreements
53 Contracts & Agreements
- Equity Distribution Agreements (2 contracts)
- Exchange Agreements (5)
- Loan Agreements (1)
- Note Agreements (5)
- Purchase Agreements (7)
- Registration Rights Agreements (2)
- Release Agreements (3)
- Stock Agreements (7)
- Subscription Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (18)
- Exchange Agreement between Altimmune, Inc. and Venrock Healthcare Capital Partners II, L.P., Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings II, LLC and... (Filed With SEC on February 25, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on February 25, 2021)
- Equity Distribution Agreement, dated February 25, 2021, by and among Altimmune, Inc. and Piper Sandler & Co., Evercore Group L.L.C. and B. Riley Securities, Inc (Filed With SEC on February 25, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on July 16, 2020)
- Underwriting Agreement, dated as of July 13, 2020, among Altimmune, Inc. and Jefferies LLC, Evercore Group L.L.C. and Piper Sandler & Co., as representatives of the underwriters... (Filed With SEC on July 16, 2020)
- Equity Distribution Agreement, dated March 27, 2020, by and among Altimmune, Inc. and JMP Securities LLC (Filed With SEC on March 27, 2020)
- Release of Claims Agreement, by and between the Company and Dr. Tasker, dated June 17, 2019 (Filed With SEC on August 13, 2019)
- Form of Securities Purchase Agreement among Altimmune, Inc. and certain investors (Filed With SEC on March 11, 2019)
- Form of Warrant (Filed With SEC on March 11, 2019)
- Form of Pre-funded Warrant (Filed With SEC on March 11, 2019)
- Form of Restricted Stock Agreement under the Altimmune, Inc. 2018 Inducement Grant Plan (Filed With SEC on December 3, 2018)
- Form of Non-Qualified Stock Option Agreement under the Altimmune, Inc. 2018 Inducement Grant Plan (Filed With SEC on December 3, 2018)
- General Release, dated as of November 30, 2018, by and between William J. Enright and Altimmune, Inc (Filed With SEC on December 3, 2018)
- Form of Securities Purchase Agreement among Altimmune, Inc. and certain investors (Filed With SEC on October 9, 2018)
- Form of Warrant (Filed With SEC on October 9, 2018)
- Form of Pre-funded Warrant (Filed With SEC on October 9, 2018)
- Form of Underwriters Warrant (Filed With SEC on September 26, 2018)
- Form of Warrant (Filed With SEC on September 26, 2018)
- Form of Pre-funded Warrant (Filed With SEC on September 26, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 26, 2018)
- Form of Securities Purchase Agreement among Altimmune, Inc. and certain investors (Filed With SEC on September 25, 2018)
- General Release, dated as of May 29, 2018, by Elizabeth A. Czerepak (Filed With SEC on August 14, 2018)
- Form of Exchange Agreement (Filed With SEC on July 16, 2018)
- Form of Exchange Note (included as Exhibit A to Exhibit 10.2 hereto) (Filed With SEC on June 25, 2018)
- Form of Exchange Note (included as Exhibit A to Exhibit 10.1 hereto) (Filed With SEC on June 25, 2018)
- [FORM OF WARRANT] ALTIMMUNE, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 17, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 17, 2017)
- 15,656 Series B Convertible Preferred Shares Warrants to Purchase 2,345,427 Common Shares ALTIMMUNE, INC. Preferred Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on August 17, 2017)
- CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT (Filed With SEC on August 14, 2017)
- NONQUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVEPLAN * * * * * (Filed With SEC on May 8, 2017)
- PHARMATHENE, INC. Up to $15,000,000 of Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 25, 2013)
- FORM OF WARRANT (Filed With SEC on April 3, 2012)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on April 3, 2012)
- OFFER TO PURCHASE (Filed With SEC on March 8, 2012)
- PHARMATHENE, INC. WARRANT TO PURCHASE COMMON STOCK To Purchase _________ Shares of Common Stock (Filed With SEC on June 10, 2011)
- Form of Unit Subscription Agreement SUBSCRIPTION AGREEMENT (Filed With SEC on June 10, 2011)
- FORM OF RESTRICTED STOCK AGREEMENT (Filed With SEC on May 11, 2011)
- PHARMATHENE,INC. 4,300,000Shares of Common Stock UnderwritingAgreement (Filed With SEC on November 1, 2010)
- COMMONSTOCK PURCHASE WARRANT PHARMATHENE,INC. (Filed With SEC on July 20, 2010)
- COMMONSTOCK PURCHASE WARRANT PHARMATHENE,INC. (Filed With SEC on April 8, 2010)
